When Epidemiology Goes Astray: Valuing Cancer Care In The United States And Europe

Health Affairs

Archives

In a recent Health Affairs paper, we documented that the United States has a significant survival advantage over much of Europe when it comes to cancer: 1.8 years for those diagnosed during our study window. Furthermore, we showed over a 17-year period Read More...

Read the complete post at http://healthaffairs.org/blog/2012/05/14/when-epidemiology-goes-astray-valuing-cancer-care-in-the-united-states-and-europe/


Posted May 14 2012, 10:51 AM by Health Affairs Blog